• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰腺腺癌中与外泌体和脂质代谢相关的基因:预后分析。

Exosome and lipid metabolism-related genes in pancreatic adenocarcinoma: a prognosis analysis.

机构信息

Department of Gastroenterology, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.

Institute of Nature Conservation, Polish Academy of Sciences, Krakow, Poland.

出版信息

Aging (Albany NY). 2023 Oct 18;15(20):11331-11368. doi: 10.18632/aging.205130.

DOI:10.18632/aging.205130
PMID:37857015
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10637811/
Abstract

OBJECTIVE

The purpose of the study was to investigate the role of exosome and lipid metabolism-related genes (EALMRGs) mRNA levels in the diagnosis and prognosis of Pancreatic Adenocarcinoma (PAAD).

METHODS

The mRNA expression pattern of PAAD and pan-cancers with prognostic data were obtained from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) database. EALMRGs were acquired from GeneCards and MSigDB database after merging and deduplication. Prognostic EALMRGs were screened through univariate COX regression analysis, and a prognostic model was constructed based on these genes by least absolute shrinkage and selection operator (LASSO) regression. The prognostic value of EALMRGs was then validated in pan-cancer data. The time characteristics ROC curve analysis was performed to evaluate the effectiveness of the prognostic genes.

RESULTS

We identified 5 hub genes (ABCB1, CAP1, EGFR, PPARG, SNCA) according to high and low-risk groups of prognoses. The risk formula was verified in three other cohort of pancreatic cancer patients and was explored in pan-cancer data. Additionally, T cell and dendritic cell infiltration was significantly increased in low-risk group. The expression of the 5 hub genes was also identified in single-cell sequencing data of pancreatic cancer with pivotal pathways. Additionally, functional enrichment analysis based on pancreatic cancer data in pancreatic cancer showed that protein serine/threonine kinase activity, focal adhesion, actin binding, cell-substrate junction, organic acid transport, and regulation of transporter activity were significant related to the expression of genes in EALMRGs.

CONCLUSIONS

Our risk formula shows potential prognostic value in multiple cancers and manifest pivotal alterations in immune infiltration and biological pathway in pancreatic cancer.

摘要

目的

本研究旨在探讨外泌体和脂质代谢相关基因(EALMRGs)mRNA 水平在胰腺导管腺癌(PAAD)诊断和预后中的作用。

方法

从癌症基因组图谱(TCGA)和基因表达综合数据库(GEO)数据库中获取 PAAD 和具有预后数据的泛癌mRNA 表达谱。从 GeneCards 和 MSigDB 数据库合并和去重后获得 EALMRGs。通过单因素 COX 回归分析筛选预后 EALMRGs,并基于这些基因通过最小绝对收缩和选择算子(LASSO)回归构建预后模型。然后在泛癌数据中验证 EALMRGs 的预后价值。通过时间特征 ROC 曲线分析评估预后基因的有效性。

结果

根据预后高低风险组,我们鉴定出 5 个枢纽基因(ABCB1、CAP1、EGFR、PPARG、SNCA)。风险公式在另外 3 个胰腺癌患者队列中得到验证,并在泛癌数据中进行了探索。此外,低风险组中 T 细胞和树突状细胞浸润明显增加。在胰腺癌的单细胞测序数据中也鉴定出这 5 个枢纽基因,并有重要的途径。此外,基于胰腺癌数据的功能富集分析表明,蛋白丝氨酸/苏氨酸激酶活性、焦点黏附、肌动蛋白结合、细胞-基质连接、有机酸转运和转运体活性的调节与 EALMRGs 中基因的表达显著相关。

结论

我们的风险公式在多种癌症中显示出潜在的预后价值,并在胰腺癌中表现出显著的免疫浸润和生物学途径改变。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0618/10637811/dc1af45fa734/aging-15-205130-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0618/10637811/9fba6688b96b/aging-15-205130-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0618/10637811/17145015fb7a/aging-15-205130-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0618/10637811/14c7f545f2d6/aging-15-205130-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0618/10637811/7a39cbcb3823/aging-15-205130-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0618/10637811/22ecabde5b01/aging-15-205130-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0618/10637811/265af2d8df0d/aging-15-205130-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0618/10637811/03045e3567a0/aging-15-205130-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0618/10637811/9e9b26520271/aging-15-205130-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0618/10637811/fe59ccfaf2cd/aging-15-205130-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0618/10637811/57ab4c295142/aging-15-205130-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0618/10637811/69e44dd09d96/aging-15-205130-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0618/10637811/dc1af45fa734/aging-15-205130-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0618/10637811/9fba6688b96b/aging-15-205130-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0618/10637811/17145015fb7a/aging-15-205130-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0618/10637811/14c7f545f2d6/aging-15-205130-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0618/10637811/7a39cbcb3823/aging-15-205130-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0618/10637811/22ecabde5b01/aging-15-205130-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0618/10637811/265af2d8df0d/aging-15-205130-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0618/10637811/03045e3567a0/aging-15-205130-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0618/10637811/9e9b26520271/aging-15-205130-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0618/10637811/fe59ccfaf2cd/aging-15-205130-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0618/10637811/57ab4c295142/aging-15-205130-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0618/10637811/69e44dd09d96/aging-15-205130-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0618/10637811/dc1af45fa734/aging-15-205130-g012.jpg

相似文献

1
Exosome and lipid metabolism-related genes in pancreatic adenocarcinoma: a prognosis analysis.胰腺腺癌中与外泌体和脂质代谢相关的基因:预后分析。
Aging (Albany NY). 2023 Oct 18;15(20):11331-11368. doi: 10.18632/aging.205130.
2
System analysis based on the pyroptosis-related genes identifies GSDMC as a novel therapy target for pancreatic adenocarcinoma.基于细胞焦亡相关基因的系统分析鉴定 GSDMC 为胰腺腺癌的一个新治疗靶点。
J Transl Med. 2022 Oct 5;20(1):455. doi: 10.1186/s12967-022-03632-z.
3
Development and Validation of an Inflammatory Response-Related Gene Signature for Predicting the Prognosis of Pancreatic Adenocarcinoma.用于预测胰腺腺癌预后的炎症反应相关基因特征的开发与验证
Inflammation. 2022 Aug;45(4):1732-1751. doi: 10.1007/s10753-022-01657-6. Epub 2022 Mar 23.
4
Construction of a five-gene prognostic model based on immune-related genes for the prediction of survival in pancreatic cancer.构建基于免疫相关基因的五个基因预后模型,用于预测胰腺癌的生存情况。
Biosci Rep. 2021 Jul 30;41(7). doi: 10.1042/BSR20204301.
5
Identification of novel potential homologous repair deficiency-associated genes in pancreatic adenocarcinoma via WGCNA coexpression network analysis and machine learning.通过 WGCNA 共表达网络分析和机器学习鉴定胰腺腺癌中新型潜在同源修复缺陷相关基因。
Cell Cycle. 2023 Nov;22(21-22):2392-2408. doi: 10.1080/15384101.2023.2293594. Epub 2024 Jan 18.
6
Identification of the Real Hub Gene and Construction of a Novel Prognostic Signature for Pancreatic Adenocarcinoma Based on the Weighted Gene Co-expression Network Analysis and Least Absolute Shrinkage and Selection Operator Algorithms.基于加权基因共表达网络分析和最小绝对收缩与选择算子算法鉴定胰腺腺癌真正的核心基因并构建新型预后特征
Front Genet. 2021 Aug 20;12:692953. doi: 10.3389/fgene.2021.692953. eCollection 2021.
7
Identification of a Four Cancer Stem Cell-Related Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Adenocarcinoma.鉴定四个与癌症干细胞相关的基因特征,并建立一个预测胰腺腺癌总生存的预后列线图。
Comb Chem High Throughput Screen. 2022;25(12):2070-2081. doi: 10.2174/1386207325666220113142212.
8
Identification and Validation of Three PDAC Subtypes and Individualized GSVA Immune Pathway-Related Prognostic Risk Score Formula in Pancreatic Ductal Adenocarcinoma Patients.胰腺导管腺癌患者中三种胰腺癌亚型的鉴定与验证以及个体化基因集变异分析(GSVA)免疫途径相关预后风险评分公式
J Oncol. 2021 Dec 27;2021:4986227. doi: 10.1155/2021/4986227. eCollection 2021.
9
, A Key Predictor of Prognosis for Pancreatic Adenocarcinoma, Significantly Regulates Cell Cycles, Apoptosis, and Metastasis., 一种胰腺腺癌预后的关键预测因子,显著调控细胞周期、凋亡和转移。
Front Immunol. 2022 Jan 27;13:805311. doi: 10.3389/fimmu.2022.805311. eCollection 2022.
10
High expression of LAMA3/AC245041.2 gene pair associated with KRAS mutation and poor survival in pancreatic adenocarcinoma: a comprehensive TCGA analysis.LAMA3/AC245041.2 基因对高表达与胰腺腺癌 KRAS 突变和不良预后相关:TCGA 综合分析。
Mol Med. 2021 Jun 16;27(1):62. doi: 10.1186/s10020-021-00322-2.

引用本文的文献

1
Integrative machine learning and bioinformatics analysis to identify cellular senescence-related genes and potential therapeutic targets in ulcerative colitis and colorectal cancer.整合机器学习和生物信息学分析以鉴定溃疡性结肠炎和结直肠癌中细胞衰老相关基因及潜在治疗靶点。
Front Bioinform. 2025 Jul 28;5:1599098. doi: 10.3389/fbinf.2025.1599098. eCollection 2025.
2
Multi-Omic Analysis Reveals a Lipid Metabolism Gene Signature and Predicts Prognosis and Chemotherapy Response in Thyroid Carcinoma.多组学分析揭示甲状腺癌脂质代谢基因特征并预测预后及化疗反应
Cancer Med. 2025 Mar;14(6):e70819. doi: 10.1002/cam4.70819.
3

本文引用的文献

1
Differential expression and bioinformatics analysis of exosome circRNAs in pancreatic ductal adenocarcinoma.胰腺导管腺癌中外泌体环状RNA的差异表达及生物信息学分析
Transl Oncol. 2023 Jul;33:101686. doi: 10.1016/j.tranon.2023.101686. Epub 2023 May 12.
2
Differences in genome, transcriptome, miRNAome, and methylome in synchronous and metachronous liver metastasis of colorectal cancer.结直肠癌同步性和异时性肝转移中基因组、转录组、微小RNA组和甲基化组的差异。
Front Oncol. 2023 Apr 27;13:1133598. doi: 10.3389/fonc.2023.1133598. eCollection 2023.
3
Prospective Analysis of Proteins Carried in Extracellular Vesicles with Clinical Outcome in Hepatocellular Carcinoma.
SNCA is a potential therapeutic target for COVID-19 infection in diffuse large B-cell lymphoma patients.
SNCA 是弥漫性大 B 细胞淋巴瘤患者 COVID-19 感染的潜在治疗靶点。
Apoptosis. 2024 Oct;29(9-10):1454-1465. doi: 10.1007/s10495-024-01996-9. Epub 2024 Jul 15.
细胞外囊泡携带蛋白与肝细胞癌临床结局的前瞻性分析
Curr Genomics. 2022 Jun 10;23(2):109-117. doi: 10.2174/1389202923666220304125458.
4
Lipid metabolism characterization in gastric cancer identifies signatures to predict prognostic and therapeutic responses.胃癌中的脂质代谢特征可识别预测预后和治疗反应的特征。
Front Genet. 2022 Nov 3;13:959170. doi: 10.3389/fgene.2022.959170. eCollection 2022.
5
Metabolic reprogramming of immune cells in pancreatic cancer progression.胰腺癌进展过程中免疫细胞的代谢重编程
Biomed Pharmacother. 2023 Jan;157:113992. doi: 10.1016/j.biopha.2022.113992. Epub 2022 Nov 14.
6
identification and verification of ferroptosis-related genes in type 2 diabetic islets.鉴定和验证 2 型糖尿病胰岛中的铁死亡相关基因。
Front Endocrinol (Lausanne). 2022 Aug 5;13:946492. doi: 10.3389/fendo.2022.946492. eCollection 2022.
7
Focal adhesion kinase priming in pancreatic cancer, altering biomechanics to improve chemotherapy.胰腺癌中的黏着斑激酶的激活,改变生物力学以改善化疗。
Biochem Soc Trans. 2022 Aug 31;50(4):1129-1141. doi: 10.1042/BST20220162.
8
Exploring the Potential of Exosome-Related LncRNA Pairs as Predictors for Immune Microenvironment, Survival Outcome, and Microbiotain Landscape in Esophageal Squamous Cell Carcinoma.探讨外泌体相关长链非编码 RNA 对作为预测食管鳞癌免疫微环境、生存结局和微生物组景观的标志物的潜力。
Front Immunol. 2022 Jul 8;13:918154. doi: 10.3389/fimmu.2022.918154. eCollection 2022.
9
ABC transporters in breast cancer: their roles in multidrug resistance and beyond.ABC 转运蛋白在乳腺癌中的作用:多药耐药及其他方面。
J Drug Target. 2022 Nov;30(9):927-947. doi: 10.1080/1061186X.2022.2091578. Epub 2022 Jun 26.
10
Development of a Prognostic Model Based on Pyroptosis-Related Genes in Pancreatic Adenocarcinoma.基于胰腺腺癌中细胞焦亡相关基因构建预后模型。
Dis Markers. 2022 May 29;2022:9141117. doi: 10.1155/2022/9141117. eCollection 2022.